A new gene therapy is giving people born deaf the chance to hear
↗AAV-mediated gene therapy delivering the OTOF gene via a single cochlear injection restored hearing in 10 congenitally deaf patients within weeks, with a favorable safety profile and funding from Otovia Therapeutics; implications include expansion to other deafness genes.
Apr 4, 20261%